0001920819-24-000001.txt : 20240612 0001920819-24-000001.hdr.sgml : 20240612 20240611174513 ACCESSION NUMBER: 0001920819-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240612 DATE AS OF CHANGE: 20240611 EFFECTIVENESS DATE: 20240612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stride Therapy, Inc. CENTRAL INDEX KEY: 0001920819 ORGANIZATION NAME: IRS NUMBER: 861923318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515734 FILM NUMBER: 241036938 BUSINESS ADDRESS: STREET 1: 41 FLATBUSH AVE, STE 217 CITY: BROOKLYN STATE: NY ZIP: 11217 BUSINESS PHONE: 484-838-6258 MAIL ADDRESS: STREET 1: 41 FLATBUSH AVE, STE 217 CITY: BROOKLYN STATE: NY ZIP: 11217 D 1 primary_doc.xml X0708 D LIVE 0001920819 Stride Therapy, Inc. 41 FLATBUSH AVE, STE 225 BROOKLYN NY NEW YORK 11217 484-838-6258 DELAWARE None None Corporation true 2021 Ryan Limor c/o Stride Therapy, Inc. 41 Flatbush Ave, Ste 225 Brooklyn NY NEW YORK 11217 Executive Officer Director Promoter Daniel Blank c/o Stride Therapy, Inc. 41 Flatbush Ave, Ste 225 Brooklyn NY NEW YORK 11217 Executive Officer Director Promoter Other Technology Decline to Disclose 06b false 2024-05-28 false true false 0 5000000 3500000 1500000 The Total Offering Amount and Total Amount Sold includes the conversion of $2,000,000 in outstanding convertible securities. false 18 0 0 0 false Stride Therapy, Inc. /s/ Ryan Limor Ryan Limor Chief Executive Officer 2024-06-11